- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: ERBB4.
Displaying page 1 of 1.
EudraCT Number: 2014-001968-35 | Sponsor Protocol Number: SPIROTREAT | Start Date*: 2015-03-11 | |||||||||||
Sponsor Name:Klinikum der Universität München - AöR vertreten durch den Vorstand des Bereiches umanmedizinH | |||||||||||||
Full Title: Add-on spironolactone for the treatment of schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003644-37 | Sponsor Protocol Number: HE6B/16 | Start Date*: 2017-08-01 | |||||||||||
Sponsor Name:Hellenic Cooperative Oncology Group (HeCOG) | |||||||||||||
Full Title: Single-arm phase II study of panitumumab rechallenge in combination with oxaliplatin or irinotecan-based chemotherapy in patients with RAS wild type advanced colorectal cancer. | |||||||||||||
Medical condition: RAS wild type advanced colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) CY (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007027-40 | Sponsor Protocol Number: 0205-1isni07 / 001.112 | Start Date*: 2008-03-07 | |||||||||||
Sponsor Name:Centre Georges-François Leclerc | |||||||||||||
Full Title: A Multicenter open-label, phase I/II dose escalation study of oral lapatinib in combination with docetaxel in patients with HER2 positive advanced or metastatic breast cancer | |||||||||||||
Medical condition: HER 2 positive advanced or metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004299-41 | Sponsor Protocol Number: ERMES | Start Date*: 2014-12-24 | |||||||||||
Sponsor Name:Dipartimento di Scienze Mediche Oncologia Medica Policlinico Gemelli | |||||||||||||
Full Title: ERbitux MEtastatic colorectal cancer Strategy Study: A phase III randomized two arm study with FOLFIRI + Cetuximab until disease progression compared to FOLFIRI + Cetuximab for 8 cycles followed by... | |||||||||||||
Medical condition: Patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
